INFU (InfuSystems Holdings) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


INFU InfuSystems Holdings Inc INFU
88 GF Score
Price $9.15
GF Value $9.44
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is InfuSystems Holdings Research & Development?

InfuSystems Holdings INFU +0.77% 88 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates INFU with a GF Score™ of 88/100 and a GF Value™ of $9.44 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. InfuSystems Holdings's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

InfuSystems Holdings  (AMEX:INFU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

InfuSystems Holdings Research & Development Related Terms

InfuSystems Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for InfuSystems Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InfuSystems Holdings Research & Development Chart

InfuSystems Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

InfuSystems Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
INFU
88GF Score
InfuSystems Holdings Inc INFU
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InfuSystems Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
InfuSystems Holdings (INFU) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on InfuSystems Holdings and its competitors.
Is InfuSystems Holdings' Research & Development too high?
InfuSystems Holdings' current Research & Development is $0.0 Mil. Overall, InfuSystems Holdings has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' Research & Development compare to TANAF and INGN?
InfuSystems Holdings' Research & Development of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on InfuSystems Holdings and its competitors. InfuSystems Holdings's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $9.15 — trading 3.1% below its estimated fair value. The current Research & Development is $0.0 Mil. InfuSystems Holdings' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InfuSystems Holdings (INFU) Overvalued in 2026?

Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be undervalued. The current stock price of $9.15 is trading 3.1% below its estimated GF Value™ of $9.44. GuruFocus considers InfuSystems Holdings to be Fairly Valued.

Key valuation signals for INFU:

  • Research & Development: $0.0 Mil
  • GF Value™: $9.44 vs. price of $9.15 (3.1% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InfuSystems Holdings Business Description

Other Exchanges 1TZ:Germany
Address 3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
88GF Score

Get the complete analysis for INFU

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.15
Price
$9.44
GF Value